EUVIMEDEUVIMED entdecken
Crossref

Discovery of Cu(II)‐Dipyridophenazine Complex for Synergistic Cuproptosis/Chemodynamic Therapy via Disrupting the Tricarboxylic Acid (TCA) Cycle in Metastatic TNBC

Ayushi Chaudhary, Ashwini Kumar, Ankit Ankit, Ritika Gautam Singh iD

Small · 2025-07 · 21 (26)

DOI: 10.1002/smll.202504554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 09.05.2025. Verfasst von Ayushi Chaudhary und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kanpur, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India. Hauptthemen laut MEDLINE: Apoptosis, Copper, Phenazines, Coordination Complexes. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a recently recognized regulated cell death, distinct from established death mechanisms, offers promising cancer therapy. However, its efficacy relies on intracellular copper availability and homeostasis. Herein, a novel Copper(II) dipyridohenazine complex, Cu(L 1 ) 2 Cl acts as an oxidative stress amplifier and glutathione (GSH) disrupter for synergistic cuproptosis/chemodynamic anticancer therapy for the treatment of challenging triple negative breast cancer. Cu(L 1 ) 2 Cl followed the endocytosis pathway to enter tumor cells and depleted GSH to release Cu + ions which result in the production of . OH radicals generated from H 2 O 2 , leading to chemodynamic therapy. The spike in ROS generation disrupts cellular redox homeostasis, causing impaired mitochondrial function, ATP depletion, and endoplasmic reticulum stress generation. ATP depletion directly affects the function of copper‐transporting ATPase 1 (ATP7A), resulting in a large amount of Cu + trapped inside cancer cells, causing oligomerization of dihydrolipoamide S‐acetyltransferase (DLAT), and depletion of Lipoyl synthase (LIAS), and leading to cellular cuproptosis. Subsequently, Cu(L 1 ) 2 Cl interrupts tumor metastasis and evokes immunogenic cell death (ICD) by promoting high mobility group protein (HMGB1), ATP and lactate dehydrogenase (LDH) release, calreticulin (CRT) exposure, and inhibiting programmed death ligand 1 (PD‐L1). The in vivo studies on 4T1 tumor bearing Balb/c mice validate its potent antitumor efficacy, thereby providing a new therapeutic paradigm to augment cuproptosis‐related therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCopperPhenazinesCoordination ComplexesNeoplasmsAntineoplastic AgentsHumansAnimalsMiceMice, Inbred BALB CCell Line, TumorReactive Oxygen SpeciesOxidative StressGlutathione

Stichwörter der Autor:innen

chemodynamic therapycuproptosisimmunogenic cell deathmetastasissynergistic therapy

Substanzen

CopperPhenazinesCoordination ComplexesReactive Oxygen SpeciesAntineoplastic AgentsGlutathione

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Kanpur, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.

ORCID-Profile: Ritika Gautam Singh

Zitieren

APA

Chaudhary, A., Kumar, A., Ankit, A., & Singh, R. G. (2025). Discovery of Cu(II)‐Dipyridophenazine Complex for Synergistic Cuproptosis/Chemodynamic Therapy via Disrupting the Tricarboxylic Acid (TCA) Cycle in Metastatic TNBC. Small, 21(26). https://doi.org/10.1002/smll.202504554

Vancouver

Chaudhary A, Kumar A, Ankit A, Singh RG. Discovery of Cu(II)‐Dipyridophenazine Complex for Synergistic Cuproptosis/Chemodynamic Therapy via Disrupting the Tricarboxylic Acid (TCA) Cycle in Metastatic TNBC. Small. 2025;21(26). doi:10.1002/smll.202504554

BibTeX
@article{Chaudhary2025,
  author = {Chaudhary, Ayushi and Kumar, Ashwini and Ankit, Ankit and Singh, Ritika Gautam},
  title = {Discovery of Cu(II)‐Dipyridophenazine Complex for Synergistic Cuproptosis/Chemodynamic Therapy via Disrupting the Tricarboxylic Acid (TCA) Cycle in Metastatic TNBC},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {26},
  doi = {10.1002/smll.202504554}
}
Kostenlos starten →